BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 28168196)

  • 1. Preoperative Gamma-Glutamyltransferase Is Associated with Cancer-Specific Survival and Recurrence-Free Survival of Nonmetastatic Renal Cell Carcinoma with Venous Tumor Thrombus.
    Luo C; Xu B; Fan Y; Yu W; Zhang Q; Jin J
    Biomed Res Int; 2017; 2017():3142926. PubMed ID: 28168196
    [No Abstract]   [Full Text] [Related]  

  • 2. Preoperative serum-gamma-glutamyltransferase (GGT) does not represent an independent prognostic factor in a European cohort of patients with non-metastatic renal cell carcinoma.
    Dalpiaz O; Pichler M; Mrsic E; Reitz D; Krieger D; Venturino L; Bezan A; Stojakovic T; Pummer K; Zigeuner R; Hutterer GC
    J Clin Pathol; 2015 Jul; 68(7):547-51. PubMed ID: 25862811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of hypertension on preoperative neutrophil-lymphocyte ratio evaluation of prognosis of renal cell carcinoma.
    Sun J; Ning H; Sun J; Qu X
    Urol Oncol; 2016 May; 34(5):239.e9-15. PubMed ID: 26803433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased preoperative levels of plasma fibrinogen and D dimer in patients with renal cell carcinoma is associated with poor survival and adverse tumor characteristics.
    Erdem S; Amasyali AS; Aytac O; Onem K; Issever H; Sanli O
    Urol Oncol; 2014 Oct; 32(7):1031-40. PubMed ID: 25027687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphovascular invasion in clear cell renal cell carcinoma--association with disease-free and cancer-specific survival.
    Belsante M; Darwish O; Youssef R; Bagrodia A; Kapur P; Sagalowsky AI; Lotan Y; Margulis V
    Urol Oncol; 2014 Jan; 32(1):30.e23-8. PubMed ID: 23428539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for recurrence after surgery in non-metastatic RCC with thrombus: a contemporary multicentre analysis.
    Abel EJ; Margulis V; Bauman TM; Karam JA; Christensen WP; Krabbe LM; Haddad A; Golla V; Wood CG
    BJU Int; 2016 Jun; 117(6B):E87-94. PubMed ID: 26305276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.
    Volpe A; Novara G; Antonelli A; Bertini R; Billia M; Carmignani G; Cunico SC; Longo N; Martignoni G; Minervini A; Mirone V; Simonato A; Terrone C; Zattoni F; Ficarra V; ;
    BJU Int; 2012 Jul; 110(1):76-83. PubMed ID: 22044519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative multivariable prognostic models for prediction of survival and major complications following surgical resection of renal cell carcinoma with suprahepatic caval tumor thrombus.
    Haddad AQ; Leibovich BC; Abel EJ; Luo JH; Krabbe LM; Thompson RH; Heckman JE; Merrill MM; Gayed BA; Sagalowsky AI; Boorjian SA; Wood CG; Margulis V
    Urol Oncol; 2015 Sep; 33(9):388.e1-9. PubMed ID: 26004163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factor for Korean patients with renal cell carcinoma and venous tumor thrombus extension: application of the new 2009 TNM staging system.
    Cho MC; Kim JK; Moon KC; Kim HH; Kwak C
    Int Braz J Urol; 2013; 39(3):353-63. PubMed ID: 23849567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positive vascular wall margins have minimal impact on cancer outcomes in patients with non-metastatic renal cell carcinoma (RCC) with tumour thrombus.
    Abel EJ; Carrasco A; Karam J; Tamboli P; Delacroix S; Vaporciyan AA; Wood CG
    BJU Int; 2014 Nov; 114(5):667-73. PubMed ID: 24128265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative pulmonary embolism does not predict poor postoperative outcomes in patients with renal cell carcinoma and venous thrombus.
    Abel EJ; Wood CG; Eickstaedt N; Fang JE; Kenney P; Bagrodia A; Youssef RF; Sagalowsky AI; Margulis V
    J Urol; 2013 Aug; 190(2):452-7. PubMed ID: 23434945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of tumor extension into venous system in patients undergoing surgical treatment for renal cell carcinoma with venous tumor thrombus.
    Miyake H; Terakawa T; Furukawa J; Muramaki M; Fujisawa M
    Eur J Surg Oncol; 2012 Jul; 38(7):630-6. PubMed ID: 22494774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of predictive accuracy of four prognostic models for nonmetastatic renal cell carcinoma after nephrectomy: a multicenter European study.
    Cindolo L; Patard JJ; Chiodini P; Schips L; Ficarra V; Tostain J; de La Taille A; Altieri V; Lobel B; Zigeuner RE; Artibani W; Guillé F; Abbou CC; Salzano L; Gallo C
    Cancer; 2005 Oct; 104(7):1362-71. PubMed ID: 16116599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type II papillary histology predicts poor outcome in patients with renal cell carcinoma and vena cava thrombus.
    Kim KH; You D; Jeong IG; Kwon TW; Cho YM; Hong JH; Ahn H; Kim CS
    BJU Int; 2012 Dec; 110(11 Pt B):E673-8. PubMed ID: 22973869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low Skeletal Muscle as a Risk Factor for Worse Survival in Nonmetastatic Renal Cell Carcinoma with Venous Tumor Thrombus.
    Schmeusser BN; Midenberg E; Palacios AR; Ali AA; Patil DH; Higgins M; Nabavizadeh R; Croll B; Williams M; Sheehy J; Zheng B; Narayan VM; Joshi SS; Ogan K; Psutka SP; Bilen MA; Master VA
    Clin Genitourin Cancer; 2023 Aug; 21(4):475-482.e4. PubMed ID: 37210313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pretherapeutic gamma-glutamyltransferase is an independent prognostic factor for patients with renal cell carcinoma.
    Hofbauer SL; Stangl KI; de Martino M; Lucca I; Haitel A; Shariat SF; Klatte T
    Br J Cancer; 2014 Oct; 111(8):1526-31. PubMed ID: 25117808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and oncological outcomes in Chinese patients with renal cell carcinoma and venous tumor thrombus extension: single-center experience.
    Chen X; Li S; Xu Z; Wang K; Fu D; Liu Q; Wang X; Wu B
    World J Surg Oncol; 2015 Feb; 13():14. PubMed ID: 25650039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of preoperative lymphocyte to monocyte ratio in patients with nonmetastatic clear cell renal cell carcinoma.
    Chang Y; Fu Q; Xu L; Zhou L; Liu Z; Yang Y; Lin Z; Xu J
    Tumour Biol; 2016 Apr; 37(4):4613-20. PubMed ID: 26508025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of venous tumour thrombus consistency (solid vs friable) on cancer-specific survival in patients with renal cell carcinoma.
    Bertini R; Roscigno M; Freschi M; Strada E; Angiolilli D; Petralia G; Matloob R; Sozzi F; Capitanio U; Da Pozzo LF; Colombo R; Guazzoni G; Cremonini A; Montorsi F; Rigatti P
    Eur Urol; 2011 Aug; 60(2):358-65. PubMed ID: 21640483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural history of untreated renal cell carcinoma with venous tumor thrombus.
    Reese AC; Whitson JM; Meng MV
    Urol Oncol; 2013 Oct; 31(7):1305-9. PubMed ID: 22237466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.